What a difference a month makes in the never-boring world of weight-loss drugs. Last month—when the news was so bullish that semaglutides (or GLP-1s, as this class of drugs is known) such as Ozempic and Wegovy might also cure all addiction—Morgan Stanley analystsraise...
Novo Nordiskis currently worth more than $550 billion, making it Europe’s most valuable company by a wide margin. The pharmaceutical giant specializes in diabetes and weight-loss drugs. Demand for two of them, Ozempic and Wegovy, hassurgeddue to their weight-loss capabilities, even causing nat...
Labya concludes: “In light of the waning demand for COVID-19 products, the biopharmaceutical companies that reaped success in 2023 have shifted to those that have developed weight loss drugs, such as Lilly and Novo Nordisk. However, ot...
Sales of potent weight loss drugs, like Ozempic, are booming. But it’s not just humans who are overweight. Now the pet care industry is dreaming of treating chubby cats and dogs, too. (Bloomberg) hide by Antonio Regalado Share story on linkedin Share story on facebook Share st...
Companies from Walmart Inc. to Conagra Brands Inc. are weighing how much to factor thediabetes drugsknown as GLP-1s, increasingly being used for weight loss, into their strategies. Moves they make now could reverberate for years to come, so the pressure's high to get it right. ...
(NYSE:LLY) is one of the world's largestpharmaceutical companies. Its main revenue drivers are diabetes drugs, and it was the first company to mass-produce insulin and the polio vaccine. Eli Lilly also manufactures antidepressants, most notably Prozac, along with weight-loss drugs. And it's ...
Loans Banking Mortgages Insurance Credit Monitoring Personal Finance Small Business Taxes Help for Low Credit Scores Investing USA INTL watch now Biden administration releases prices of 10 drugs in Medicare talks watch now AI models are becoming more specialized for industries, DeepL CEO says ...
Taxes Help for Low Credit Scores Investing USA INTL European SpaceX rival raises $160 million for reusable space capsule Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS watch now Merck KGaA continues focus on strengthening pipeline with innovation: CFO ...
It also includes each organization’s top-selling drugs and R&D investment totals. While Big Pharma, by and large, remains a picture of strength and stability, highlighted, in some cases, by exponential and unprecedented financial growth, for the companies making up the Pharma 50, it has not ...
European companies LVMH overtakes Novo Nordisk as Europe’s most valuable company Luxury bellwether regains crown as drugmaker slips on concerns it will have to cut weight loss medication prices in US Drug prices Obesity drugs Ozempic and Wegovy included in US price-cut talks ...